RdRP-IN-4
RdRP-IN-4 (11q) is an orally bioavailable arylbenzohydrazide inhibitor targeting the PB1 subunit of influenza virus RdRp. It demonstrates potent in vitro activity against influenza A (H1N1) and B strains with EC50 values of 53 nM and 20 nM, respectively, and has shown significant antiviral efficacy in mouse infection models.
Product Specifications
Field of Research
Infectious Disease & Virology
Molecular Formula
C17H17Br2N3O2
Molecular Weight
455.14
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472726-500 1x 500 µL
N-Myc (Neuroblastoma Marker) (NMYC-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC683607-100 1x 100 µL
Von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker) (rVWF/2480), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details